Fundraising Fox

Scholar Rock

NASDAQ: SRRK

Cambridge, US · Delaware LLC · 4 known investors

scholarrock.com ↗

Scholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases. The company uses a selective protein targeting approach designed to inhibit disease mechanisms rather than manage their downstream effects.

Biotechin /scholar-rock@ScholarRock

Founders & leadership

KB
Kristina BurowDirector
KB
Katrine BosleyDirector
AN
Amir NashatDirector
MG
Michael GilmanDirector
NM
Nagesh MahanthappaExecutive Officer, Director
TS
Timothy SpringerDirector

Investors · 4

Aisling CapitalNew York
ARCH Venture PartnersChicago · $50K – $250Mvia Kristina Burow · board
EcoR1 CapitalSan Francisco
Polaris PartnersreportedBoston · $500K – $5Mvia Amir Nashat · board

Reported raises · per SEC filings

Form D private placements
▶$36.3MraisedJan 2016 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kristina BurowDirector
  • Katrine BosleyDirector
  • Amir NashatDirector
  • Michael GilmanDirector
  • Nagesh MahanthappaExecutive Officer, Director
  • Timothy SpringerDirector
Offering amount
$40M
Amount sold
$36.3M
First sale
Dec 2015
Incorporated
Limited Liability Company, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.